New study aims to unravel fatigue in common nerve disease
NCT ID NCT07066683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looks at fatigue in people with Charcot-Marie-Tooth type 1A (CMT1A), a nerve disorder affecting arms and legs. Researchers will compare 22 patients with 22 healthy volunteers to measure how fatigue affects walking and balance. They use tests like muscle strength measurements and questionnaires to understand both perceived tiredness and physical fatigability.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better understanding of fatigue in CMT1A, helping design future treatments or therapies to improve mobility and quality of life.
- What could go wrong
- This is a small pilot study (44 participants) that only observes and measures, not testing a treatment. Results may not apply to all CMT1A patients or lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 44 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 74 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria for patients: * Age ≥ 18 years and \< 75 years * Patient with mCMT1A confirmed by genetic analysis (based on data recorded in the patient file) * Patient able to walk a minimum of 200 metres without a break, with or without equipment and/or technical aids (collected during questioning) * Patient able to get on and off a cycloergometer safely without assistance or with minimal assistance * Patient who has had a cardiological check-up before the stress test (ECG and cardiac ultrasound less than 6 months old) or for whom a check-up is scheduled before the inclusion * Patient affiliated to a health insurance scheme or beneficiary of such a scheme Inclusion criteria for Healthy volunteers: * Age ≥ 18 years and \< 75 years * Subject affiliated to or benefiting from a health insurance scheme * Subject who has had a cardiological work-up prior to stress testing (ECG and cardiac ultrasound less than 6 months old) or for whom a work-up is scheduled prior to the procedure. Exclusion criteria for patients: * Patients with all other forms of neuropathy (HNPP, other types of CMT, secondary neuropathies) * Patients with any of the following * An associated neurological disease other than mCMT1A * Severe joint disease of the lower limbs * Contraindication to isokinetic testing * Contraindication to an exercise stress test and exercise reconditioning program * A contraindication to Transcranial Magnetic Stimulation (TMS) : epilepsy, intracranial metallic foreign body, hearing aid or cochlear implant, unstable skull bone fracture, deafness, etc. * Patients who have undergone lower limb surgery in the 12 months prior to inclusion or for whom lower limb surgery is scheduled during the participation period. * Pregnant or breastfeeding or planning to become pregnant within the next 4 months * BMI \> 35 kg/m2 * Patient unable to give informed consent, unable to understand informed information * Subject under court protection * Subject under guardianship or curatorship * Subject in a period of exclusion (determined by a previous or current study) Exclusion criteria for healthy volunteers: * History of neurological disease * Severe joint damage in the lower limbs * Any of the following * Contraindication to isokinetic testing * A contraindication to an exercise stress test and an exercise reconditioning program * A contraindication to TMS: epilepsy, intracranial metallic foreign body, hearing aid or cochlear implant, unstable skull bone fracture, deafness, etc. * Any person who has undergone surgery on the lower limbs in the 12 months prior to inclusion, or for whom surgery on the lower limbs is scheduled during the participation period. * Pregnant or breastfeeding, or planning to become pregnant within the next 4 months * Person unable to give informed consent, unable to understand informed information * BMI \> 35 kg/m2 * Person under legal protection * Person under guardianship or curatorship * Person in a period of exclusion (determined by a previous or current study)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Charcot-Marie-Tooth type 1A are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pôle de médecine physique et de réadaptation, Hôpital de Hautepierre, Strasbourg Centre de référence des maladies neuromusculaires, Institut Universitaire de Réadaptation Clémenceau, Strasbourg
Strasbourg, 67000, France